Exploring the Interplay of Mental and Metabolic Factors in Erectile Dysfunction Management: A Case Report
Background: Erectile dysfunction (ED) affects 20-50% of men globally and considerably diminishes the patients’ and their partners’ quality of life. This condition has multifactorial causes, including depression and metabolic syndrome, resulting in a complicated interaction of physical and psychological components.
Case: A man in his mid-twenties presented to the Andrology outpatient clinic at Dr. Soetomo General Hospital with a sudden onset of ED, reporting a decrease in his Erection Hardness Score (EHS) from 3-4 to 1 following penetration attempts. He had a history of childhood attention deficit hyperactivity disorder (ADHD) and recent unemployment, resulting in profound depression. Prior inconsistent treatments encompassed sertraline, fluvoxamine, and clobazam. Physical and laboratory examinations revealed metabolic syndrome. The patient was diagnosed with severe ED secondary to mixed etiology, class II obesity, major depressive episode, and metabolic syndrome. He received education on the diagnosis, possible underlying causes, and management options.
Discussion: The case presented illustrates the intricate interplay between ED and comorbidities such as depression and metabolic syndrome. Depression exacerbates ED through hormonal dysregulation and reduced parasympathetic activity, while metabolic syndrome contributes to ED through endothelial dysfunction and nitric oxide (NO) depletion. Effective ED management requires a multidisciplinary approach, combining lifestyle modifications, psychological support, and pharmacological treatment. Tailored strategies addressing both physical and psychological aspects are essential for improving outcomes.
Conclusion: Comprehensive and integrative care in managing ED, particularly when associated with complex comorbidities, is needed to enhance the patient’s erectile function and quality of life.
Aleksandra R, Aleksandra S, Iwona R. Erectile Dysfunction in Relation to Metabolic Disorders and the Concentration of Sex Hormones in Aging Men. Int J Environ Res Public Health. 2022 Jul;19(13).
Katsimardou A, Patoulias D, Zografou I, Siskos F, Stavropoulos K, Imprialos K, et al. The Impact of Metabolic Syndrome Components on Erectile Function in Patients with Type 2 Diabetes. Metabolites. 2023 May;13(5).
Xiong Y, Zhang F, Zhang Y, Wang W, Ran Y, Wu C, et al. Insights into modifiable risk factors of erectile dysfunction, a wide-angled Mendelian Randomization study. J Adv Res. 2024 Apr;58:149–61.
Yuan P, Chen Y, Sun T, Cui L, Wei Y, Li T, et al. Exploring potential genes and mechanisms linking erectile dysfunction and depression. Front Endocrinol (Lausanne). 2023;14.
Ma K, Song P, Liu Z, Yang L, Wang L, Zhou J, et al. Genetic evidence suggests that depression increases the risk of erectile dysfunction: A Mendelian randomization study. Front Genet. 2022 Oct;13.
Corona DG, Vena W, Pizzocaro A, Rastrelli G, Sparano C, Sforza A, et al. Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study. J Endocrinol Invest. 2023 Nov;46(11):2195–211.
Sood R, Sharma D, Goel H, Khattar N, Kulshreshtha B, Singh KK. The correlation between erectile dysfunction and metabolic syndrome in an Indian population: A cross-sectional observational study. Arab J Urol. 2019 Jul;17(3):221–7.
Waldinger MD. Psychiatric disorders and sexual dysfunction. In: Michael JA, François B, Dick FS, eds. Handbook of Clinical Neurology, vol. 130. Elsevier B.V. 2015:469–89.
Klaas S, Siva JB, Bak M, Govers M, Schreiber R. The pathophysiology of Post SSRI Sexual Dysfunction – Lessons from a case study. Biomed Pharmacother. 2023 May;161:114166.
Chou PS, Chou WP, Chen MC, Lai CL, Wen YC, Yeh KC, et al. Newly diagnosed erectile dysfunction and risk of depression: A population-based 5-year follow-up study in Taiwan. J Sex Med. 2015 Mar;12(3):804–12.
Argiolas A, Argiolas FM, Argiolas G, Melis MR. Erectile Dysfunction: Treatments, Advances, and New Therapeutic Strategies. Brain Sci. 2023 May;13(5):802.
Panevska L, ZafirovaIvanovska B, Vasilevska K, Isjanovska R, Kadri H. Relationship Between ADHD and Depression Among University Students in Macedonia. Materia Socio Medica. 2015;27(1):18.
Kalin NH. The critical relationship between anxiety and depression. Am J Psychiatry. 2020 May;177(5):365–7.
Chen WK, Zhou T, Yu DD, Li JP, Wu JG, Li LJ, et al. Effects of major depression and bipolar disorder on erectile dysfunction: a two-sample Mendelian randomization study. BMC Med Genomics. 2023 Dec;16(1).
Alhuwaydi A. Development of erectile dysfunction in men treated for major depressive disorder with selective serotonin reuptake inhibitors: a systematic review. Archives of Medical Science. 2020 Aug.
Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017 Jun;19(2):93–107.
Chughtai B, Lee RK, Te AE, Kaplan SA. Metabolic syndrome and sexual dysfunction. Curr Opin Urol. 2011 Nov;21(6):514–8.
Chokka PR, Hankey JR. Assessment and management of sexual dysfunction in the context of depression. Ther Adv Psychopharmacol. 2018 Jan;8(1):13–23.
Uchino BN. Understanding the Links Between Social Support and Physical Health: A Life-Span Perspective with Emphasis on the Separability of Perceived and Received Support. Perspect Psychol Sci. 2009 May;4(3):236–55.
Pakpahan C, Agustinus A, Darmadi D. Comprehensive intersystemic assessment approach to relieve psychogenic erectile dysfunction: A review. OAMJMS. 2021;9:189–96.
Copyright (c) 2025 Jesselyn Angellee, Sally Suharyani, Tjahjo Djojo Tanojo, Cennikon Pakpahan, William William, Natasha Susanto Utomo

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.